Total Payments
$942.74
2024 Payments
$18.48
Companies
12
Transactions
58
Medicare Patients
1,218
Medicare Billing
$535,943
Payment Breakdown by Category
Food & Beverage$818.27 (86.8%)
Education$124.47 (13.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $818.27 | 52 | 86.8% |
| Education | $124.47 | 6 | 13.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $296.37 | 19 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $175.29 | 10 | $0 (2019) |
| Alexion Pharmaceuticals, Inc. | $95.22 | 6 | $0 (2023) |
| Vifor Pharma, Inc. | $89.81 | 6 | $0 (2022) |
| Relypsa, Inc. | $81.65 | 5 | $0 (2019) |
| Veloxis Pharmaceuticals, Inc. | $47.36 | 3 | $0 (2018) |
| OPKO Pharmaceuticals, LLC | $36.14 | 2 | $0 (2018) |
| GlaxoSmithKline, LLC. | $35.76 | 2 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $33.35 | 2 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $25.68 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18.48 | 1 | GlaxoSmithKline, LLC. ($18.48) |
| 2023 | $35.79 | 2 | Alexion Pharmaceuticals, Inc. ($18.51) |
| 2022 | $56.34 | 3 | Vifor Pharma, Inc. ($21.54) |
| 2021 | $93.75 | 7 | Vifor Pharma, Inc. ($68.27) |
| 2020 | $56.92 | 3 | AstraZeneca Pharmaceuticals LP ($25.68) |
| 2019 | $119.15 | 7 | Otsuka America Pharmaceutical, Inc. ($39.43) |
| 2018 | $233.00 | 13 | Mallinckrodt LLC ($80.26) |
| 2017 | $329.31 | 22 | Mallinckrodt LLC ($203.50) |
All Payment Transactions
58 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/27/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: IMMUNOLOGY | ||||||
| 06/22/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Rare Disease | ||||||
| 03/01/2022 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Hyperkalemia | ||||||
| 02/01/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Rare Disease | ||||||
| 01/18/2022 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: IMMUNOLOGY | ||||||
| 11/10/2021 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Hyperkalemia | ||||||
| 10/12/2021 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Hyperkalemia | ||||||
| 06/22/2021 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: Nephrology | ||||||
| 05/17/2021 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: Hyperkalemia | ||||||
| 04/20/2021 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Hyperkalemia | ||||||
| 04/13/2021 | Alexion Pharmaceuticals, Inc. | Ultomiris (Drug) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: Immunology | ||||||
| 03/16/2021 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: Hyperkalemia | ||||||
| 08/06/2020 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $25.68 | General |
| 02/18/2020 | Alexion Pharmaceuticals, Inc. | Ultomiris (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Immunology | ||||||
| 02/04/2020 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2019 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Hyperkalemia | ||||||
| 09/10/2019 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Immunology | ||||||
| 06/03/2019 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Hyperkalemia | ||||||
| 05/06/2019 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Immunology | ||||||
| 04/09/2019 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug), JYNARQUE | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: NEPHROLOGY | ||||||
| 03/26/2019 | Mallinckrodt Enterprises LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 03/04/2019 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug), JYNARQUE | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: NEPHROLOGY | ||||||
| 09/26/2018 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Hyperkalemia | ||||||
| 07/10/2018 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug), JYNARQUE | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: NEPHROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 167 | 1,708 | $211,476 | $99,000 |
| 2022 | 7 | 192 | 571 | $269,274 | $128,218 |
| 2021 | 11 | 306 | 1,455 | $325,222 | $154,228 |
| 2020 | 16 | 553 | 7,254 | $414,847 | $154,497 |
Total Patients
1,218
Total Services
10,988
Medicare Billing
$535,943
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 38 | 271 | $155,283 | $77,222 | 49.7% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 19 | 42 | $20,202 | $9,964 | 49.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 46 | 64 | $13,760 | $5,438 | 39.5% |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 2023 | 12 | 1,250 | $11,250 | $2,874 | 25.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 21 | $7,161 | $2,614 | 36.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 14 | $2,220 | $626.04 | 28.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 22 | $1,144 | $206.34 | 18.0% |
| 85018 | Blood count, hemoglobin | Office | 2023 | 14 | 24 | $456.00 | $55.68 | 12.2% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 49 | 347 | $198,831 | $99,078 | 49.8% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 34 | 69 | $33,189 | $16,171 | 48.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 48 | 67 | $14,405 | $6,219 | 43.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 30 | $8,610 | $3,939 | 45.7% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 19 | 27 | $10,530 | $1,558 | 14.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 11 | 12 | $1,752 | $674.90 | 38.5% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 15 | 19 | $1,957 | $579.10 | 29.6% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 57 | 416 | $238,368 | $119,180 | 50.0% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 27 | 50 | $24,050 | $11,851 | 49.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 83 | 98 | $21,070 | $9,804 | 46.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 25 | 42 | $12,054 | $5,883 | 48.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 24 | 32 | $4,672 | $1,819 | 38.9% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 21 | 30 | $11,700 | $1,744 | 14.9% |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 2021 | 11 | 705 | $6,345 | $1,658 | 26.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 17 | 20 | $2,920 | $1,227 | 42.0% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 16 | 29 | $2,987 | $881.60 | 29.5% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 11 | 13 | $676.00 | $133.56 | 19.8% |
About Dr. Melanie Hames, DO
Dr. Melanie Hames, DO is a Nephrology healthcare provider based in Greenville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/18/2005. The National Provider Identifier (NPI) number assigned to this provider is 1992797716.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Melanie Hames, DO has received a total of $942.74 in payments from pharmaceutical and medical device companies, with $18.48 received in 2024. These payments were reported across 58 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($818.27).
As a Medicare-enrolled provider, Hames has provided services to 1,218 Medicare beneficiaries, totaling 10,988 services with total Medicare billing of $535,943. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Greenville, NC
- Active Since 08/18/2005
- Last Updated 02/13/2024
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1992797716
Products in Payments
- ACTHAR (Biological) $329.72
- SAMSCA (Drug) $175.29
- Veltassa (Drug) $171.46
- ULTOMIRIS (Biological) $37.15
- Rayaldee (Drug) $36.14
- BENLYSTA (Biological) $35.76
- SOLIRIS (Drug) $30.98
- Ultomiris (Drug) $27.09
- Envarsus XR (Drug) $26.47
- Envarsus XR (SP) (Drug) $20.89
- INJECTAFER (Drug) $13.67
- Parsabiv (Drug) $12.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Greenville
William Kendrick, M.d, M.D
Nephrology — Payments: $203,057
Nephrology $203,057
Dr. Barry Gorlitsky, Md, MD
Nephrology — Payments: $175,603
Nephrology $175,603
Blake Shusterman, Md, MD
Nephrology — Payments: $66,159
Nephrology $66,159
Richard Blair, M.d, M.D
Nephrology — Payments: $13,340
Nephrology $13,340
Anthony Provenzano
Nephrology — Payments: $10,873
Nephrology $10,873
Dr. Amita Patel, M.d, M.D
Nephrology — Payments: $9,091
Nephrology $9,091